Date: December 1-2, 2021

Venue: Virtual Event

Q1 Production’s premier event platform offers a refreshing and unparalleled virtual experience. Thoughtfully designed and customizable networking features foster a sense of collaboration and discussion, allowing attendees to make direct connections.

This program offers three half-day modules to maximize retention and engagement. 

• Methods of application and influence of technological advancements
• AI Integration Automation Possibilities
• Regulatory operations teams and developing strategic skill sets
• Bridging the gap between associates at the junior and senior levels
• Dealing with changes in regulatory requirements and global considerations
• Keeping up with general industry developments
• Special considerations regarding emerging markets 

Through resource management considerations, you will also look at the construction of submission dossiers and efficiency in optimizing the dossier preparation process, including technology and AI integration.

The agenda of the conference includes: 

Time-Saving Strategies to Meet Accelerated Regulatory Submission Timelines

• Allocating resources and outsourcing decisions 
• Prioritizing speed while retaining quality
• Best practices for large-scale dossier work 

• Validations 
• Hyperlinking 
• Formatting data 
• Hyperlinking Publishing

• Using automation to satisfy rising demand 
• Having a positive influence on patients in need

Module 1 of the New eCTD fFr Electronic Submissions To The U.S. FDA

Form 2253 submission for promotional materials 

• Cross-functional training on regulatory and promotional rules 
• Useful resources for additional learning and outreach 
• Setting up a consistent procedure with the promotions department using FDA advice 
• Forums and websites

The conference aims to establish parameters and educate people regarding: 

• Vendor selection and validation criteria 
• Training and automation integration for support teams 
• Demonstration of value proposition to offset upfront investment and measuring the gains in productivity due to automation

Hiring Conference

• A review of attributes regarding hiring of staff that have a high association to success 
• Techniques to expand your search and effectively interview
• A spotlight on problems related to hiring and training personnel long-term talent acquisition and retention strategy

Who Will Benefit the Most from This Conference?

• Executives working in pharmaceutical companies who are currently working to implement eCTD 4.0 and newly added promotional submissions requirements 
• Those who want to learn about viable automation solutions for workflow processes
• Those wanting to develop strategies around global submission timelines 

This program will also help you to:

• Understanding your market and how it affects your submission strategy
• Take a seat at the early product operations decision-making table
• Take on compliance as a cross-functional responsibility
• Regulatory agenda advocacy across the organization

For more information about the event, please visit https://ibn.fm/x8g5z

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.